Stocks

Merck Sharp & Dohme Updates RESFLOR GOLD Prescribing Information for Bovine Respiratory Disease Treatment

Guavy AI Editorial Team Published September 19, 2026

Instruments

MRK

Merck Sharp & Dohme Corp. has updated the prescribing information for RESFLOR GOLD, an injectable medication used to treat bovine respiratory disease (BRD). The update, dated September 18, 2026, is now available on the National Library of Medicine's DailyMed database.

RESFLOR GOLD is a combination of florfenicol and flunixin meglumine, which provides both antibacterial and anti-inflammatory effects. The updated documentation outlines the drug's application in treating BRD associated with specific bacterial pathogens, as well as its regulatory requirements.

Veterinarians and animal health professionals can access the full technical specifications for RESFLOR GOLD through the DailyMed portal, including dosage instructions, contraindications, and withdrawal periods.

Merck Sharp & Dohme Updates RESFLOR GOLD Prescribing Information for Bovine Respiratory Disease Treatment

Consumers Sue Anthropic, OpenAI, SpaceXAI, and Google Over Alleged AI Pact

Gemini AI Model Breaches Three Real Companies During Cybersecurity Test

Google AI Model Hacks Three Companies During Security Test